Profile data is unavailable for this security.
About the company
Merck KGaA is a Germany-based science and technology company. The Company operates in three business segments: Healthcare, Life Sciences and Electronics. The Healthcare business, which operates in the United States and Canada as EMD Serono, focuses on such therapeutic areas as allergies, fertility, oncology and neurodegenerative diseases, developing drugs, diagnostic substances and medical devices. The Life Sciences business comprises the activities of MilliporeSigma, which provides solutions that facilitate biotechnology and pharmaceutical research. The product range includes laboratory water systems, gene editing tools, cell lines and end-to-end drug manufacturing systems, among others. The Electronics business enables digital living and provides specialty chemicals for various applications, including liquid crystals for electronic displays, materials for integrated circuits, effect pigments for coatings and color cosmetics, as well as functional materials for energy solutions.
- Revenue in USD (TTM)24.11bn
- Net income in USD3.61bn
- Incorporated1995
- Employees64.23k
- LocationMerck KGaAFrankfurter Str. 250DARMSTADT 64293GermanyDEU
- Phone+49 6151720
- Fax+49 6 151722000
- Websitehttps://www.emdgroup.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Exact Sciences Corp | 2.08bn | -623.51m | 11.96bn | 6.30k | -- | 3.92 | -- | 5.74 | -3.54 | -3.54 | 11.82 | 17.10 | 0.3229 | 5.15 | 11.13 | 330,837.90 | -9.66 | -12.12 | -10.41 | -13.29 | 72.44 | 74.21 | -29.91 | -36.43 | 2.09 | -14.79 | 0.4247 | -- | 17.95 | 50.94 | -4.68 | -- | 25.37 | -- |
| Sarepta Therapeutics Inc | 933.01m | -703.49m | 12.01bn | 1.16k | -- | 31.20 | -- | 12.88 | -8.03 | -8.03 | 10.66 | 4.38 | 0.2973 | 0.7176 | 5.08 | 802,937.20 | -22.42 | -23.30 | -27.04 | -27.11 | 85.00 | 86.31 | -75.40 | -96.38 | 3.80 | -17.84 | 0.8005 | -- | 32.93 | 43.27 | -67.99 | -- | 7.76 | -- |
| Catalent Inc | 4.76bn | 409.00m | 12.05bn | 19.00k | 29.61 | 2.45 | 14.88 | 2.53 | 2.26 | 2.26 | 26.28 | 27.29 | 0.4456 | 4.13 | 3.67 | 250,368.40 | 3.84 | 4.59 | 4.37 | 5.21 | 32.71 | 32.74 | 8.62 | 9.40 | 1.36 | 4.43 | 0.497 | 0.00 | 20.76 | 18.39 | -4.91 | 35.58 | 36.40 | -- |
| Incyte Corporation | 3.39bn | 340.66m | 15.86bn | 2.32k | 46.75 | 3.63 | 38.83 | 4.67 | 1.52 | 1.52 | 15.16 | 19.62 | 0.6301 | 5.31 | 5.38 | 1,460,686.00 | 6.32 | 8.32 | 7.78 | 10.03 | 94.54 | 95.49 | 10.04 | 11.84 | 3.50 | 6.64 | 0.0076 | 0.00 | 13.67 | 17.18 | -64.09 | -- | -6.86 | -- |
| ICON PLC | 7.74bn | 505.30m | 17.21bn | 41.10k | 34.37 | 2.03 | 15.96 | 2.22 | 6.13 | 6.13 | 93.87 | 103.98 | 0.4478 | -- | 3.33 | 188,354.90 | 2.94 | 4.74 | 3.46 | 5.90 | 28.66 | 28.75 | 6.57 | 7.92 | -- | 3.81 | 0.3539 | -- | 41.24 | 34.50 | 229.87 | 11.77 | 26.03 | -- |
| Biomarin Pharmaceutical Inc | 2.10bn | 141.56m | 17.57bn | 3.08k | 129.00 | 3.81 | 72.15 | 8.38 | 0.7302 | 0.7302 | 11.12 | 24.71 | 0.3387 | 0.579 | 5.02 | 680,090.50 | 2.29 | -0.0866 | 2.52 | -0.0985 | 76.92 | 76.07 | 6.75 | -0.2549 | 3.15 | -- | 0.1908 | -- | 13.53 | 9.80 | 308.18 | -- | -7.97 | -- |
| Merck KGaA (ADR) | 24.11bn | 3.61bn | 23.71bn | 64.23k | 22.12 | 2.88 | 4.26 | 0.9836 | 1.66 | 1.66 | 11.08 | 12.93 | 0.4736 | 2.00 | 5.49 | 375,299.90 | 7.11 | -- | 9.05 | -- | 61.65 | 62.61 | 15.02 | 11.92 | 0.7957 | 26.91 | 0.2856 | 9.64 | 12.93 | 8.90 | 8.87 | 5.47 | -- | -- |
| Alnylam Pharmaceuticals, Inc. | 1.04bn | -1.13bn | 24.32bn | 2.00k | -- | -- | -- | 23.44 | -9.30 | -9.30 | 8.53 | -1.28 | 0.2886 | 1.57 | 6.27 | 518,190.80 | -31.47 | -32.56 | -39.51 | -38.98 | 83.73 | 84.49 | -109.04 | -168.24 | 3.34 | -3.03 | 1.18 | -- | 22.88 | 63.09 | -32.64 | -- | -7.11 | -- |
| Horizon Therapeutics PLC | 3.63bn | 521.48m | 24.88bn | 2.12k | 49.11 | 4.88 | 27.28 | 6.85 | 2.22 | 2.22 | 15.43 | 22.32 | 0.4079 | 4.66 | 5.54 | 1,715,860.00 | 5.86 | 6.52 | 6.54 | 7.55 | 74.64 | 74.05 | 14.37 | 16.80 | 3.67 | 8.79 | 0.3357 | 0.00 | 12.48 | 28.00 | -2.43 | -- | 71.34 | -- |
| Gartner Inc | 5.48bn | 807.80m | 25.17bn | 19.50k | 31.89 | 110.65 | 25.18 | 4.60 | 9.98 | 9.98 | 67.57 | 2.88 | 0.7442 | -- | 3.70 | 280,812.60 | 10.98 | 6.27 | 20.87 | 10.89 | 69.07 | 66.70 | 14.75 | 9.85 | -- | 9.59 | 0.9153 | -- | 15.67 | 10.58 | 1.79 | -- | -0.4951 | -- |
| DuPont de Nemours Inc | 13.02bn | 1.01bn | 32.46bn | 23.00k | 35.20 | 1.22 | 14.78 | 2.49 | 2.01 | 12.09 | 26.06 | 58.00 | 0.299 | 3.81 | 5.57 | 565,956.50 | 2.44 | 0.2193 | 2.74 | 0.2889 | 35.45 | 34.76 | 8.15 | 1.44 | 2.40 | 5.80 | 0.2301 | 840.00 | 3.59 | 2.21 | -12.68 | -- | -27.68 | 2.98 |
| Holder | Shares | % Held |
|---|---|---|
| Henry James International Management, Inc.as of 31 Dec 2022 | 84.70k | 0.01% |
| Envestnet Asset Management, Inc.as of 30 Nov 2022 | 34.62k | 0.01% |
| Yousif Capital Management LLCas of 31 Dec 2022 | 10.80k | 0.00% |
| Lazard Asset Management LLCas of 28 Feb 2023 | 8.85k | 0.00% |
| Yorktown Management & Research Co., Inc.as of 28 Feb 2023 | 8.45k | 0.00% |
| SYSTM Wealth Solutions LLCas of 31 Dec 2022 | 6.70k | 0.00% |
| PNC Investments LLCas of 31 Dec 2022 | 2.31k | 0.00% |
| RAM Active Investments SAas of 30 Jun 2022 | 1.80k | 0.00% |
| Thomas White International Ltd.as of 31 Dec 2022 | 1.27k | 0.00% |
| First Horizon Advisors, Inc.as of 31 Dec 2022 | 277.00 | 0.00% |
